NCT05383482 2025-11-17
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Laekna Limited
Phase 1/2 Completed
Clinical Trials
6 trialsNCT04374630 2025-09-10
PROFECTA-II
Laekna Limited
Phase 2 Completed
NCT04060394 2024-10-10
Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC
Laekna Limited
Phase 1/2 Completed
NCT05390710 2024-10-10
PhI to Solid Tumors and PhII to Locally Advanced or mTNBC
Laekna Limited
Phase 1 Completed
NCT01531894 2019-07-09
Continuation Study of the Oral AKT Inhibitor GSK2110183
Novartis
Phase 2 Completed
NCT02240212 2017-04-11
Study of Afuresertib Combined With Paclitaxel in Gastric Cancer
Novartis
Phase 1 Completed